One longtime women's health investor weighs in...
Our guide to the new regulation, plus the biggest opportunities and the challenges
Don't bank on it, at least not yet...
Why we remain bullish on services, even as the market has shifted to favor software
Important new data is out today indicating that might be the case — and for the very reason you might expect!
Health care is a tough market, but there are invariably going to be big opportunities, according to Maveron's Jason Stoffer
The incumbents have gotten a lot bigger since 2019, so digital health startups will need to change their strategy to get acquired.
Build for the needs of a community, not a single condition
RCM, transparency tools, HSA/FSAs and more
Not all companies (or hormones) are created equal
In this market, we're undervaluing and underestimating brick and mortar
Why we need a "systemic" solution to clinician burnout
The valuation may seem crazy, but it's actually not...
We return to a bold 2019 prediction from Dr. Aaron Neinstein, plus a review of Ezra's Whole Body MRI